A detailed history of Armistice Capital, LLC transactions in Grifols Sa stock. As of the latest transaction made, Armistice Capital, LLC holds 9,536,000 shares of GRFS stock, worth $74.6 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
9,536,000
Previous 7,892,000 20.83%
Holding current value
$74.6 Million
Previous $49.7 Million 70.32%
% of portfolio
1.41%
Previous 0.65%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.28 - $9.38 $10.3 Million - $15.4 Million
1,644,000 Added 20.83%
9,536,000 $84.7 Million
Q2 2024

Aug 14, 2024

BUY
$6.27 - $7.7 $7.8 Million - $9.58 Million
1,244,000 Added 18.71%
7,892,000 $49.7 Million
Q1 2024

May 15, 2024

BUY
$5.47 - $11.38 $36.4 Million - $75.7 Million
6,648,000 New
6,648,000 $44.4 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.